Clinical Trial Update: Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone [Phase 2, Phase 3]

View source ↗

Summary

This update reports on a Phase 2/Phase 3 study evaluating adrenocorticotropic hormone to treat multiple sclerosis relapses after suboptimal response to intraven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Adrenocorticotropic Hormone (adrenocorticotropic hormone)

Snippet

Sponsor: Neurologique Foundation, Inc. | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: TERMINATED